Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

BUY
$151.44 - $200.09 $1,514 - $2,000
10 New
10 $1,000
Q4 2019

Feb 10, 2020

SELL
$116.25 - $133.25 $337,125 - $386,425
-2,900 Closed
0 $0
Q2 2019

Jul 26, 2019

SELL
$97.98 - $114.28 $106,308 - $123,993
-1,085 Reduced 27.23%
2,900 $329,000
Q4 2018

Feb 04, 2019

BUY
$79.28 - $95.27 $1,347 - $1,619
17 Added 0.43%
3,985 $340,000
Q3 2018

Oct 11, 2018

BUY
$83.5 - $93.23 $39,078 - $43,631
468 Added 13.37%
3,968 $363,000
Q2 2018

Jul 30, 2018

BUY
$79.9 - $89.2 $279,650 - $312,200
3,500 New
3,500 $298,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $80.9B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Arrow Financial Corp Portfolio

Follow Arrow Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrow Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Arrow Financial Corp with notifications on news.